IP IntelligenceIP Lex ›Book a service

IP IntelligenceMythsIt was granted in another country, so India will grant it to

Patent myth

“It was granted in another country, so India will grant it too.”

MediumIP professionalEnterpriseFounder
Reality

Each office applies its own law. Indian subject-matter law differs materially, particularly on business methods, methods of treatment and new forms of known substances.

Section 3 has no exact counterpart elsewhere. Section 3(d) imposes an efficacy test on new forms of known substances that most systems do not have. The business method exclusion is absolute in India. And Indian inventive step expressly requires technical advance or economic significance. A US or European grant is useful evidence about the prior art, and no more.

What believing it costs

Prosecution strategies copied from a parent case abroad, applied to objections that do not exist there.

Sources & further reading

Related

Not sure whether this applies to your invention?

The honest answer usually needs someone to look at your actual disclosure, your timeline and the prior art. That is a conversation, not an article.

Educational guidance, not legal advice. This material is published by Ragulika IP for general education and information. It is not legal advice, it does not create a professional-client relationship, and it is not a substitute for advice on your own facts. Patentability, infringement, prosecution strategy and every other IP outcome turn on the specific facts and on the law and Patent Office practice as they stand at the time you act. Please take professional advice before making a decision, and read the underlying provision or judgment before relying on any point stated here.

Last reviewed by Ragulika IP on 2026-08-23. Indian patent law and Patent Office practice change; check the position before you rely on it.